| Registrars: | Equiniti |
| CEO: | William D Brown |
| CFO: | Lachlan Smith |
| Independent Non-Executive Director: | John Louis Ely |
| Independent Non-Executive Director: | Ian Ardill |
| Non-Executive Chairman: | Geoffrey Alan Berg |
| Non-Executive Dir: | John McKenna |
| Address: | 2 Drummond Crescent, Riverside Business Park, Irvine, Ayrshire, United Kingdom, KA11 5AN |
| Phone: | +44(0) 1294 317073 |
| Website: | http://rualifesciences.com/ |
| Sector: | Health Care(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB0033360586 |
| Currency | UK Pounds |
| Share Price | 24.00p |
| Change Today | 1.00p |
| % Change | 4.35 % |
| 52 Week High | 25.60 |
| 52 Week Low | 10.50 |
| Volume | 126,744 |
| Shares Issued | 62.06m |
| Market Cap | £14.89m |
| RiskGrade | 290 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:01 | 10,000 @ 23.98p |
| 15:52 | 15,000 @ 23.90p |
| 15:23 | 5,000 @ 23.90p |
| 15:19 | 20,000 @ 24.00p |
| 14:23 | 4,000 @ 23.57p |
| CEO | William D Brown |
| CFO | Lachlan Smith |
You are here: research